Follow The Filings

STOCK Act disclosures

LGND Ligand Pharmaceuticals Incorporated

Members of Congress who traded or hold Ligand Pharmaceuticals Incorporated, from their STOCK Act disclosures. None of the 13F managers we track hold it, so this page covers Congress only. LGND earnings.

  • 1 members traded it since Nov 22, 2023
  • 4 / 0 buys / sales
  • 0 held it at year end
  • May 29, 2026 latest trade

Trades

4 trades since Nov 22, 2023, newest filings first

  1. LGNDLigand Pharmaceuticals Incorporated
    Buy
    $1K–$15K
    Traded May 29Filed Jun 8 10d
  2. LGNDLigand Pharmaceuticals Incorporated
    Buy
    $1K–$15K
    Traded Mar 3Filed Apr 7 35d
  3. LGNDLigand Pharmaceuticals Incorporated
    Buy
    $1K–$15K
    Traded Jan 15Filed Feb 13 29d
  4. LGNDLigand Pharmaceuticals Incorporated
    Buy
    $1K–$15K
    Traded Jan 5Filed Feb 13 39d

Amounts are the ranges members disclose. Trades cover the last three years; holdings come from each member's latest annual report. See all Congress trades and how we read these reports.